Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus

Published:2012 Issue:19 Volume:51 Page:2763-2766
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ono Keiko¹²,Suzushima Hitoshi³,Watanabe Yuko³,Kikukawa Yoshitaka³,Shimomura Taizou³,Furukawa Noboru⁴²,Kawaguchi Tatsuya⁵,Araki Eiichi²

Affiliation:

1. Department of Metabolism and Endocrinology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan

2. Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Japan

3. Department of Hematology, Kumamoto Shinto General Hospital (formerly NTT West Kyushu Hospital), Japan

4. Center for Medical Education and Research, Faculty of Life Sciences, Kumamoto University, Japan

5. Department of Hematology and Infectious Diseases, Kumamoto University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/51/19/51_51.8314/_pdf

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors: a review;Frontiers in Pharmacology;2024-02-01

2. The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia;Hemato;2023-07-14

3. Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability;eBioMedicine;2023-04

4. Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies;Frontiers in Oncology;2023-02-06

5. Kinase inhibitors for cancer alter metabolism, blood glucose, and insulin;Journal of Endocrinology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3